undamentalytics Newsletter
Sign in

Novocure Ltd revenue

Novocure Ltd's revenue was $655m in fiscal 2025, up 8.3% on the year before. Since fiscal 2013 ($10.4m) it has grown at a compound 41.3% a year. Over the last twelve months it was $725m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue10153383177248351494535538509605655725
Growth on the year before—+49.5%+113.6%+150.5%+113.6%+40.1%+41.6%+40.7%+8.2%+0.5%−5.3%+18.8%+8.3%—
Gross profit351237121168263388420423381468488559

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Geography
Region Revenue YoY
United States $386M ▼ 1.6%
International Markets $250M ▲ 27.7%
Germany $79.4M ▲ 21.7%
France $76.2M ▲ 36.7%
Other International Markets $56.9M ▲ 34.0%
Japan $37.8M ▲ 16.0%
China $19.4M ▲ 11.8%

These categories overlap or exclude eliminations, so shares aren't shown.

From Novocure Ltd's 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Equipment: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Novocure Ltd $725m 12.9% 12.9%
Glaukos Corp $690m 46.9% 31.5%
Transmedics Group, Inc. $668m 25.8% 64.2%
Myriad Genetics Inc $807m -3.2% 4.9%
Irhythm Holdings, Inc. $825m 25.6% 22.2%
Orthofix Medical Inc. $833m 3.0% 11.7%

Compare with peers

Head to head: GKOS vs NVCRNVCR vs TMDXMYGN vs NVCR

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Novocure Ltd's SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Novocure Ltd.